Ira Duarte - Jun 16, 2023 Form 3 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
EVP, Chief Financial Officer
Signature
/s/ Lisa Peraza Attorney-in-fact for Ira Duarte
Stock symbol
HRTX
Transactions as of
Jun 16, 2023
Transactions value $
$0
Form type
3
Date filed
6/23/2023, 04:28 PM
Previous filing
Dec 9, 2022
Next filing
Jun 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HRTX Employee Stock Option (Right to Buy) Jun 16, 2023 Common Stock 800K $1.21 Direct F1
holding HRTX Restricted Stock Units Jun 16, 2023 Common Stock 50K $0.00 Direct F2
holding HRTX Employee Performance Stock Option (Right to Buy) Jun 16, 2023 Common Stock 500K $1.21 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable with respect to 200,000 shares on the first anniversary of the date of grant, followed by 600,000 shares vesting ratably each month over the subsequent three years, such that 800,000 options will be fully vested on the four year anniversary of the date of grant.
F2 The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.
F3 The stock option vests and becomes exercisable with respect to escalating portions of the option grant upon the Issuer's stock price reaching certain pre-established levels ranging from $4.50 to $7.50 per share, subject to the Reporting Person's continued service to the Issuer through the vesting date.